PA · VETO.PA
Vetoquinol S.A.
- Sector
- Healthcare · Drug Manufacturers - Specialty & Generic
- Headquarters
- Lure 70204
- Website
- vetoquinol.com
Price · as of 2024-12-31
$77.00
Market cap 989.97M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $118.18 | +53.48% |
| Intrinsic Value(DCF) | $37.01 | -51.94% |
| Graham-Dodd Method(GD) | $54.43 | -29.32% |
| Graham Formula(GF) | $49.02 | -36.34% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | $25.09 | $37.91 | $2.74 | $16.94 | $32.73 |
| 2011 | $20.54 | $37.46 | $3.60 | $18.77 | $17.24 |
| 2012 | $22.30 | $36.11 | $4.14 | $18.29 | $24.64 |
| 2013 | $34.03 | $51.63 | $5.18 | $19.68 | $16.95 |
| 2014 | $36.51 | $42.79 | $5.44 | $21.50 | $28.46 |
| 2015 | $33.92 | $52.11 | $1.78 | $22.20 | $33.30 |
| 2016 | $47.59 | $51.57 | $3.55 | $25.64 | $24.02 |
| 2017 | $51.89 | $64.74 | $5.60 | $30.15 | $25.57 |
| 2018 | $55.95 | $75.50 | $4.04 | $32.25 | $37.78 |
| 2019 | $58.18 | $58.90 | $0.80 | $26.59 | $37.21 |
| 2020 | $90.44 | $71.76 | $13.67 | $27.11 | $25.65 |
| 2021 | $134.27 | $123.62 | $164.42 | $49.33 | $155.05 |
| 2022 | $77.50 | $97.54 | $61.42 | $42.80 | $46.95 |
| 2023 | $102.51 | $101.36 | $6.68 | $49.68 | $29.19 |
| 2024 | $72.33 | $118.18 | $12.82 | $54.42 | $49.02 |
AI valuation
Our deep-learning model estimates Vetoquinol S.A.'s (VETO.PA) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $118.18
- Current price
- $77.00
- AI upside
- +53.48%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$37.01
-51.94% upside
Graham-Dodd
$54.43
-29.32% upside
Graham Formula
$49.02
-36.34% upside
About Vetoquinol S.A.
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, and dogs. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.
- CEO
- Matthieu Frechin
- Employees
- 2.52K
- Beta
- 1.02
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($37.01 ÷ $77.00) − 1 = -51.94% (DCF, example).